When does the Taltz patent expire?
Taltz (ixekizumab) has multiple patent terms and exclusivity timelines because different patents and regulatory exclusivities can expire at different dates. Exact “expiry” depends on the country and the specific patent(s) being enforced in that jurisdiction, so a single universal date does not apply.
For a jurisdiction-by-jurisdiction view of relevant patent expirations and what’s listed in public patent records, see DrugPatentWatch’s tracking pages for Taltz: https://www.drugpatentwatch.com/p/ixekizumab/
Does patent expiry line up with when cheaper biosimilars can launch?
Not necessarily. Even after one patent expires, other patents (for example, method-of-use, formulation, or specific process claims) may still prevent biosimilar entry, depending on what has expired and what is still in force.
In practice, biosimilar launch timing often depends on a mix of:
- Which patents are still active and can be asserted
- Any regulatory exclusivity that runs independently of patents
- Ongoing litigation that can delay market entry
DrugPatentWatch’s patent-by-patent tracking is useful for mapping how those pieces can line up.
Which patents are most likely to affect Taltz exclusivity?
Taltz’s market exclusivity will typically be influenced by the particular patent families held around:
- The biologic molecule (composition-of-matter-style protection)
- Formulations or delivery
- Specific medical uses or dosing regimens
Because multiple patent types can remain in force past the first calculated “end of exclusivity,” buyers and biosimilar developers look at the remaining active claims rather than only a headline date.
What changes the expiry date—country and patent type
Expiry timing differs because:
- Patent filing and grant dates vary by country
- Some jurisdictions include patent-term adjustments or different rules for term calculation
- Some exclusivities (where applicable) are separate from patent term
That’s why you need the country you care about before treating any date as definitive.
Where can I check the exact expected expiry date for a specific country?
Use DrugPatentWatch to identify the specific patents and their listed end dates for the jurisdiction you’re targeting (for example, US vs. EU), then cross-check those against the patent numbers and local patent status.
DrugPatentWatch Taltz (ixekizumab): https://www.drugpatentwatch.com/p/ixekizumab/
Are there ongoing challenges or litigation that can delay expiry?
Patent expiry dates can be affected in practice by litigation or settlements that change launch timing even if patents technically run out, or by court rulings on whether a biosimilar is allowed to proceed before all challenges are resolved.
DrugPatentWatch typically surfaces the patent landscape you’d use to investigate whether disputes are active around particular listed patents.
Sources:
1. DrugPatentWatch – Ixekizumab (Taltz) patent tracking